CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

European Journal of Immunology

Volumn 31, Issue 10, 2001, Pages 3121-3126

  Jacobs, Roland ^a   Hintzen, Gabriele ^a   Kemper, Almut ^a   Beul, Katrin ^a   Kempf, Sandra ^a   Behrens, Georg ^a   Sykora, Karl Walter ^a   Schmidt, Reinhold E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CD56bright; CD56dim; KIR; KLR; NK cell

Indexed keywords

CD158A ANTIGEN; CD158B ANTIGEN; CD161 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; GRANZYME A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; KIR RECEPTOR; KLR RECEPTOR; LECTIN RECEPTOR; NKB1 RECEPTOR; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR; KLRD1 PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PORE FORMING CYTOTOXIC PROTEIN;

ARTICLE; CELL MATURATION; CONJUGATION; CONTROLLED STUDY; CYTOLYSIS; DENSITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; KILLER CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOTOXICITY; IMMUNOLOGY; NATURAL KILLER CELL;

ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD94; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 0034740653     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4     Document Type: Article

References (35)

1. Biology of natural killer cells
2. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
3. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles
4. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies
5. Natural killer cell receptors and MHC class I interactions
6. NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules
7. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
8. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells
9. Inhibitory MHC class I receptors on NK cells and T cells
10. CD56bright natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand
11. Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients
12. + natural killer cells after bone marrow transplantation
13. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: The FcR gamma III (CD16) molecule and NK cell differentiation
14. Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins
15. Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes
16. Characterization of functional surface structures on human natural killer cells
17. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes
18. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
19. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
20. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
21. A human killer inhibitory receptor specific for HLA-A1. 2
22. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells
23. HLA-E binds to natural killer cell receptors CD94/NKG2A. B and C
24. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
25. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16-CD56bright natural killer cells
26. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells
27. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis
28. Kinetics of in vitro natural killer activity against K562 cells as detected by flow cytometry
29. Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis
30. Specific release of proteoglycans from human natural killer cells during target lysis
31. Perforin-mediated target cell lysis by cytolytic T lymphocytes
32. + T cells
33. Debate: The mechanism of lymphocyte-mediated killing. Perforin-induced pore formation
34. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines
35. Immunologic and virologic studies in long-term nonprogressors with HIV-1 infection